顕微鏡的多発性血管炎(Microscopic Polyangiitis (MPA)）：治療薬のグローバル治験動向（2014年下半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables4
List of Figures 5
Introduction 6
Microscopic Polyangiitis (MPA) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Microscopic Polyangiitis (MPA) to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Microscopic Polyangiitis (MPA) to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Microscopic Polyangiitis (MPA) 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Microscopic Polyangiitis (MPA) Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
F. Hoffmann-La Roche Ltd. 30
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 30
Zenyaku Kogyo Co., Ltd. 31
Clinical Trial Overview of Zenyaku Kogyo Co., Ltd. 31
Teijin Limited 32
Clinical Trial Overview of Teijin Limited 32
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Anthera Pharmaceuticals‚ Inc. 34
Clinical Trial Overview of Anthera Pharmaceuticals‚ Inc. 34
Clinical Trial Overview of Top Institutes / Government 35
Assistance Publique – Hopitaux de Paris 35
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 35
University of Pennsylvania 36
Clinical Trial Overview of University of Pennsylvania 36
Cambridge University Hospitals NHS Foundation Trust 37
Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust 37
Saitama Medical University 38
Clinical Trial Overview of Saitama Medical University 38
University Hospitals Birmingham NHS Foundation Trust 39
Clinical Trial Overview of University Hospitals Birmingham NHS Foundation Trust 39
University Medical Center Groningen 40
Clinical Trial Overview of University Medical Center Groningen 40
The National Institute of Allergy and Infectious Diseases 41
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 41
Hospices Civils de Lyon 42
Clinical Trial Overview of Hospices Civils de Lyon 42
University of Oxford 43
Clinical Trial Overview of University of Oxford 43
Massachusetts General Hospital 44
Clinical Trial Overview of Massachusetts General Hospital 44
Five Key Clinical Profiles 45
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 77